YD Bio YDES
NASDAQ YDES
$2.63 +0.00 (+0.19%)
As of: Sep 22, 2026 · 11:58 AM EDT

YD Bio (YDES) Non-Current Deferred Tax Liability (2024)

YD Bio's (YDES) quarterly Non-Current Deferred Tax Liability came in at $1463.0 in Q4 2024.

Analysis

YD Bio (YDES) Non-Current Deferred Tax Liability (2024) Analysis & Trends

YD Bio (YDES) has reported Non-Current Deferred Tax Liability for 1 consecutive years, with $1463.0 the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $1463.0 in Q4 2024; TTM through Dec 2024 was $1463.0, a N/A change from a year earlier, with the FY2024 full-year figure at $1463.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability was $1463.0 for Q4 2024 at YD Bio.
  • Over five years, Non-Current Deferred Tax Liability peaked at $1463.0 in Q4 2024 and troughed at $1463.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 YD Bio 225.82 Mn 223.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,463.00
API Access

YD Bio Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=YDES&period=max&api_key=YOUR_API_KEY